abstract |
The present invention relates to an immunogenic composition comprising a) a modified live H3 virus of swine influenza, and b) a modified live H1 virus of swine influenza. Moreover, the invention relates to a method of immunizing a subject, comprising administering to the subject an immunogenic composition of the invention. Moreover, the present invention provides a method for treating or preventing a clinical symptom induced by swine influenza virus, comprising administering to the subject a therapeutically effective amount of an immunogenic composition according to the present invention, / RTI > of the invention. |